Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 23, 2021
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
[ Thu, Sep 23rd 2021
] - WOPRAI
Wed, September 22, 2021
[ Wed, Sep 22nd 2021
] - WOPRAI
Jim Birchenough Maintained (ADAP) at Hold with Increased Target to $7 on, Sep 22nd, 2021
Jim Birchenough of Wells Fargo, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Increased Target from $6 to $7 on, Sep 22nd, 2021.
Jim has made no other calls on ADAP in the last 4 months.
There are 2 other peers that have a rating on ADAP. Out of the 2 peers that are also analyzing ADAP, 1 agrees with Jim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Chang of "SVB Leerink" Maintained at Hold with Increased Target to $7 on, Monday, September 13th, 2021
This is the rating of the analyst that currently disagrees with Jim
- Peter Lawson of "Barclays" Initiated at Sell and Held Target at $4 on, Friday, May 28th, 2021
